Clinical Trials Logo

Chronic Obstructive Lung Disease clinical trials

View clinical trials related to Chronic Obstructive Lung Disease.

Filter by:

NCT ID: NCT01602237 Completed - Rhinitis Clinical Trials

Preventing Respiratory Health Problems in Bakery Employees

Baker2012
Start date: February 2012
Phase: N/A
Study type: Observational

The study is a follow-up of investigations done in the years 1999-2002 in bakery employees. The main purposes are to look at the associations between flour dust exposure and respiratory disease, and to find out the best ways to reduce the flour dust levels in the working environment.

NCT ID: NCT01596023 Completed - Clinical trials for Chronic Obstructive Lung Disease

Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients

Start date: May 2012
Phase: N/A
Study type: Interventional

The Breathe Ventilator is a lightweight, wearable ventilator that has received U.S. FDA clearance for use in patients with respiratory difficulty. The investigators believe that the Breathe NIOV system will reduce the work of the diaphragm and breathing by providing added tidal volume and oxygen. This will be a study in 14 patients with severe-to-very severe chronic obstructive lung disease (COPD) to assess their work of breathing while using the NIOV system as measured by esophageal and stomach pressures.

NCT ID: NCT01495780 Completed - COPD Clinical Trials

eRT Remote Health Monitoring

Start date: January 2012
Phase: N/A
Study type: Interventional

Remote Health Monitoring (RHM) is the assessment of one's own symptoms at home between doctor visits, using things like at-home breathing tests, electronic diaries to answer questionnaires, and other monitoring devices. The hypothesis of this study is that the health and quality of life of people with COPD who do RHM for one year will be better than people with COPD who do not do RHM. Subjects who are at least 40 years old, have been diagnosed with chronic obstructive pulmonary disease (COPD), also known as chronic bronchitis or emphysema, and are current or former smokers will be invited to participate. This study is paid for by eResearch Technology (eRT). Subjects will complete 2 visits at UCLA, separated by one year of RHM. All subjects will participate in RHM. RHM will involve daily monitoring at home using a few electronic devices: blood oxygen levels, symptoms, medication use, breathing tests, and activity monitoring. Visits will include physical exam and medical history, ECG, questionnaires, breathing tests, and exercise tests.

NCT ID: NCT01416701 Withdrawn - Clinical trials for Chronic Obstructive Lung Disease

Vitamin D and Chronic Obstructive Lung Disease

Start date: September 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the effect of vitamin D intervention in patients with chronic obstructive pulmonary disease (COPD) undergoing rehabilitation.

NCT ID: NCT01404000 Completed - Clinical trials for Chronic Obstructive Lung Disease

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal

Start date: November 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study s to determine whether treatment with Iodinated Active Charcoal can improve lung function and physical capacity in patients with chronic obstructive lung disorders. The rational for the study is the observation that COPD patients have an increased tissue load of mercury interfering with the function by NeuroEpithelial Endocrine (NEE) cells in the respiratory tract. Mercury binding to these NEE cells leads to an increased smooth muscle tonus and a reduced response to bronchodilator treatment. Initial observational data have shown an improved lung function and improved functional capacity after treatment motivating a larger placebo controlled POC study

NCT ID: NCT01362855 Completed - Cancer Clinical Trials

Advance Care Planning Evaluation in Hospitalized Elderly Patients

ACCEPT
Start date: September 2011
Phase:
Study type: Observational

The purpose of the study is to inform decision-makers of the best strategies to implement advanced care planning (ACP). An advanced care plan (ACP) is a verbal or written instruction describing what kind of care an individual would want (or not want)if they are no longer able speak for themselves to make health care decisions.

NCT ID: NCT01355978 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

PRIDE
Start date: August 2011
Phase: N/A
Study type: Interventional

When using the Breathe Technologies Ventilation System during simulated activities of daily living (ADLs), Subjects with moderate-to-severe chronic obstructive pulmonary Disease (COPD) will be comfortable and report acceptability.

NCT ID: NCT01347931 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

In-home Evaluation of a Noninvasive Open Ventilation System in Patients With Severe Respiratory Insufficiency

Start date: May 2011
Phase: N/A
Study type: Interventional

The Breathe NIOV™ System will reduce the work of breathing in subjects with chronic respiratory insufficiency who require long-term oxygen therapy (LTOT). The Breathe system will accomplish this by providing oxygen under pressure and augmenting the subject's spontaneous tidal volumes. The combination of efficient oxygen delivery, assisted ventilation, and a comfortable low-profile device, will result in a mean improvement in perceived well-being and ability to perform ADLs, as measured by patient-reported outcome (PRO) instruments.

NCT ID: NCT00814203 Completed - Clinical trials for Chronic Obstructive Lung Disease

A Registry of COPD Patients to be Used for Future Studies

Start date: December 2008
Phase:
Study type: Observational

To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.

NCT ID: NCT00506701 Withdrawn - Clinical trials for Chronic Obstructive Lung Disease

Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

Start date: February 2008
Phase: N/A
Study type: Interventional

Tadalafil may lower the pulmonary artery pressure in patients with Chronic Obstructive Lung Disease and secondary pulmonary hypertension and thereby improve patients quality of life.